Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Making the American Dream Possible again in Week 44 of the Trump Presidency.
-
PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in preclinical studies Provisional patent application on the novel drug delivery...
-
Assays are still pending for 80 holes from this year’s exploration campaign, of which 62 (representing 78% of the total pending) contain visible gold to the naked eye (VG-NE); see images & table...
-
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and...
-
Infographics accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ec2df2de-dfb1-4a07-8407-651fd33a4858 ...
-
FORT WORTH, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- SEGG Media Corporation (Nasdaq: SEGG, LTRYW) (“SEGG Media” or “the Company”), parent company of Sports.com, today announced its latest...
-
Week 42 of the Trump Presidency does not slow down and does not disappoint.
-
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) Oral presentation to report results from real...
-
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) Oral presentation reports about 9 out of every...
-
Week 41 of America under the leadership of President Trump and the Trump Administration.